32 pending office actions • 7 clients
| Client (Assignee) | Pending OAs |
|---|---|
| The Johns Hopkins University | 23 |
| The Johns Hopkins University | 3 |
| Johns Hopkins University | 2 |
| UNIVERSITY OF WASHINGTON | 1 |
| Renmin Hospital Of Wuhan University | 1 |
| Stichting VU | 1 |
| UNIVERSITY OF WASHINGTON | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18972277 | IN SITU NUCLEIC ACID ANALYSIS USING PROBE PAIR LIGATION | The Johns Hopkins University | SISSON, BRADLEY L | 1682 | Non-Final OA | Dec 06, 2024 |
| 18670928 | NANOFIBER-HYDROGEL COMPOSITES FOR ENHANCED SOFT TISSUE REPLACEMENT AND REGENERATION | The Johns Hopkins University | WRIGHT, SARAH C | 1619 | Non-Final OA | May 22, 2024 |
| 18566519 | BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS | UNIVERSITY OF WASHINGTON | BARRON, SEAN C | 1653 | Non-Final OA | Dec 01, 2023 |
| 18286185 | TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL | The Johns Hopkins University | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Oct 09, 2023 |
| 18284040 | HYDRODYNAMIC GENE DELIVERY | Johns Hopkins University | HARRIS, WESLEY G | 3783 | Non-Final OA | Sep 25, 2023 |
| 18278998 | THERAPEUTIC COMPOSITIONS AND METHODS | Johns Hopkins University | CESARE, JOSEPH DAVID | 1675 | Non-Final OA | Aug 25, 2023 |
| 18268893 | DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION | The Johns Hopkins University | GRAY, JESSICA | 1682 | Non-Final OA | Jun 21, 2023 |
| 18202066 | MAP KINASE PATHWAY TARGETS FOR THE TREATMENT OF MARFAN SYNDROME | The Johns Hopkins University | HAM, JIEUN | 1643 | Non-Final OA | May 25, 2023 |
| 18200526 | COMPOSITE MATERIAL FOR TISSUE RESTORATION | The Johns Hopkins University | SHIN, MONICA A | 1616 | Final Rejection | May 22, 2023 |
| 18024662 | TREATMENT OF VASCULAR EHLERS-DANLOS SYNDROME AND RELATED SYNDROMES | The Johns Hopkins University | SHIAO, REI TSANG | 1691 | Non-Final OA | Mar 03, 2023 |
| 18042912 | JUVENILE PROTECTIVE FACTORS TO ARREST AND REVERSE AGING IN THE ENTERIC NERVOUS SYSTEM | The Johns Hopkins University | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Feb 24, 2023 |
| 18015684 | COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY | The Johns Hopkins University | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Jan 11, 2023 |
| 18004030 | METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA | Renmin Hospital Of Wuhan University | SITTON, JEHANNE SOUAYA | 1682 | Non-Final OA | Dec 30, 2022 |
| 17993555 | BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS | The Johns Hopkins University | PHAN, DOAN THI-THUC | 1613 | Final Rejection | Nov 23, 2022 |
| 17919152 | CRYBETAB2 PREDICTS POOR BREAST CANCER OUTCOME AND SENSITIZES TUMORS TO NUCLEOLIN AND CDK INHIBITION | The Johns Hopkins University | HOPPE, EMMA RUTH | 1683 | Non-Final OA | Oct 14, 2022 |
| 17793207 | COMPOSITE MATERIALS AND EMBOLIZATION METHODS | The Johns Hopkins University | SCOTLAND, REBECCA LYNN | 1615 | Final Rejection | Jul 15, 2022 |
| 17789858 | FUSION PROTEINS AND METHODS OF USE THEREOF | The Johns Hopkins University | ZINGARELLI, SANDRA | 1653 | Final Rejection | Jun 29, 2022 |
| 17789099 | ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS | The Johns Hopkins University | BEANE, RANDALL L | 1654 | Final Rejection | Jun 24, 2022 |
| 17779936 | METHODS AND COMPOSITIONS FOR ANALYSES OF CANCER | Stichting VU | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | May 25, 2022 |
| 17770531 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | The Johns Hopkins University | REGA, KYLE THOMAS | 1636 | Final Rejection | Apr 20, 2022 |
| 17769705 | EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE TREATMENT OF NEUROPATHIC DISORDERS | UNIVERSITY OF WASHINGTON | WANG, CHANG YU | 1675 | Non-Final OA | Apr 15, 2022 |
| 17641417 | ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS AND TISSUE | The Johns Hopkins University | SCHLIENTZ, LEAH H | 1618 | Final Rejection | Mar 08, 2022 |
| 17622037 | COMPOSITIONS AND METHODS FOR LYME DISEASE | The Johns Hopkins University | IVICH, FERNANDO NMN | 1678 | Final Rejection | Dec 22, 2021 |
| 17621122 | DNA MARKERS FOR DIFFERENTIATION OF BIOPSY SAMPLES | The Johns Hopkins University | GIAMMONA, FRANCESCA FILIPPA | 1681 | Final Rejection | Dec 20, 2021 |
| 17604255 | Methods for Detecting and Treating Esophageal Cancer | The Johns Hopkins University | CHUNDURU, SURYAPRABHA | 1681 | Final Rejection | Oct 15, 2021 |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | The Johns Hopkins University | MINCHELLA, KAITLYN L | 1685 | Non-Final OA | Mar 17, 2021 |
| 17194177 | GLP-1R AGONIST AND METHODS OF TREATMENT | The Johns Hopkins University | HIBBERT, CATHERINE S | 1658 | Non-Final OA | Mar 05, 2021 |
| 16956537 | BAFF THERAPY TO PROMOTE ANTI-TUMOR IMMUNITY | The Johns Hopkins University | AEDER, SEAN E | 1642 | Final Rejection | Jun 19, 2020 |
| 16864130 | ORGAN DIRECTED GENE DELIVERY | The Johns Hopkins University | SHIN, DANA H | 1635 | Final Rejection | Apr 30, 2020 |
| 16753567 | IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME | The Johns Hopkins University | BROWE, DAVID | 1617 | Non-Final OA | Apr 03, 2020 |
| 16467890 | ORTHOGONAL TRANSCRIPTIONAL SWITCHES DERIVED FROM TET REPRESSOR HOMOLOGS FOR SACCHAROMYCES CEREVISIAE | The Johns Hopkins University | KONOPKA, CATHERINE ANNE | 1635 | Non-Final OA | Jun 07, 2019 |
| 16341862 | COMPOSITIONS AND METHODS FOR IDENTIFYING FUNCTIONAL ANTI-TUMOR T CELL RESPONSES | The Johns Hopkins University | JUEDES, AMY E | 1644 | Final Rejection | Apr 12, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial